[1] |
国家药典委员会. 中华人民共和国药典一部: 2020年版[M]. 北京: 中国医药科技出版社, 2020.
|
[2] |
JIANG Z T, HAN Y, ZHANG Y C, et al. Sedum sarmentosum bunge attenuates drug-induced liver injury via Nrf2 signaling pathway: an experimental verification based on network pharmacology prediction[J]. Journal of Healthcare Engineering, 2021, 2021: 1142638. DOI: 10.1155/2021/1142638.
|
[3] |
杨迎迎, 万新焕, 刘英男, 等. 垂盆草化学成分及药理作用研究进展[J]. 中国中药杂志, 2020, 45(18): 4341-4348. DOI: 10.19540/j.cnki.cjcmm.20200623.601.
|
[4] |
王黎芳, 杨中. 垂盆草配方颗粒联合谷胱甘肽治疗HBV阳性妊娠肝功能异常的疗效观察[J]. 中国现代药物应用, 2022, 16(7): 99-101. DOI: 10.14164/j.cnki.cn11-5581/r.2022.07.035.
|
[5] |
潘易发, 向张娟. 复方垂盆草胶囊辅治乙型病毒性肝炎临床观察[J]. 实用中医药杂志, 2021, 37(8): 1324-1325.
|
[6] |
尹登采. 复方垂盆糖草浆治疗利福平引起的血清SGPT增高40例[J]. 中西医结合杂志, 1991, 11(8): 464. DOI: 10.7661/CJIM.1991.8.464.
|
[7] |
NIU X F, LIU X, PAN L, et al. Oleanene triterpenes from Sedum lineare thunb[J]. Fitoterapia, 2011, 82(7): 960-963. DOI: 10.1016/j.fitote.2011.05.011.
|
[8] |
ZONG T Q, JIANG Z, ZHOU Y, et al. Chemical constituents from the whole plants of Sedum sarmentosum Bunge and their chemotaxonomic significance[J]. Biochemical Systematics and Ecology, 2020, 93: 104180. DOI: 10.1016/j.bse.2020.104180.
|
[9] |
李慧娟, 杜成林, 李娜, 等. 垂盆草的化学成分分离鉴定[J]. 中国实验方剂学杂志, 2017, 23(4): 76-80. DOI: 10.13422/j.cnki.syfjx.2017040076.
|
[10] |
JIANG Z T, WANG X, WANG J C, et al. Simultaneous determination of eight flavonoids in Sedum sarmentosum Bunge from different areas by UHPLC with triple quadrupole MS/MS[J]. Biomedical Chromatography: BMC, 2019, 33(9): e4601. DOI: 10.1002/bmc.4601.
|
[11] |
何冰, 马生健, 何旭东. 垂盆草总黄酮含量测定及分析[J]. 农产品加工, 2022(18): 71-73. DOI: 10.16693/j.cnki.1671-9646(X).2022.09.056.
|
[12] |
LIU Z X, LIU D, CHEN M Y, et al. Effects of Sedi Herba (Sedum sarmentosum) on attenuating cholestasis by the activation of the farnesoid x receptor (FXR)-mediated signaling[J]. Biomedicine & Pharmacotherapy, 2022, 155: 113803. DOI: 10.1016/j.biopha.2022.113803.
|
[13] |
CHEN M Z, SUN Q. Systemic pharmacology understanding of the key mechanism of Sedum sarmentosum Bunge in treating hepatitis[J]. Naunyn-Schmiedeberg’s Archives of Pharmacology, 2021, 394(2): 421-430. DOI: 10.1007/s00210-020-01952-9.
|
[14] |
LU H, CHENG S B, WU C Z, et al. Sedum sarmentosum Bunge extract alleviates inflammation and kidney injury via inhibition of M1-macrophage polarization[J]. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 2019, 62: 152976. DOI: 10.1016/j.phymed.2019.152976.
|
[15] |
赵娜, 黄丽华. 垂盆草总黄酮对肝损伤大鼠肝细胞活性的作用机制[J]. 世界中西医结合杂志, 2022, 17(9): 1745-1750. DOI: 10.13935/j.cnki.sjzx.220910.
|
[16] |
LIU J H, ZHONG X H, JIANG Y Y, et al. Systematic identification metabolites of Hemerocallis citrina Borani by high-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry combined with a screening method[J]. Journal of Pharmaceutical and Biomedical Analysis, 2020, 186: 113314. DOI: 10.1016/j.jpba.2020.113314.
|
[17] |
张传洋, 郑振兴, 王迪, 等. 基于UPLC-Q-Orbitrap HRMS的锦灯笼化学成分分析[J]. 中药材, 2021, 44(11): 2590-2598. DOI: 10.13863/j.issn1001-4454.2021.11.017.
|
[18] |
马丹阳, 高雪嫣, 彭凌峰, 等. 基于UHPLC-QE-Orbitrap-MS技术的深加工槟榔籽的成分分析[J]. 畜牧兽医学报, 2023, 54(12): 5275-5292.
doi: 10.11843/j.issn.0366-6964.2023.12.036
|
[19] |
李思洁, 王雪宁, 胡军华, 等. 基于UPLC-Q-TOF-MS/MS技术解析玉女颗粒化学成分[J]. 中草药, 2023, 54(23): 7730-7741. DOI: 10.7501/j.issn.0253-2670.2023.23.015.
|
[20] |
陈雨洁, 林亲雄, 万定荣, 等. 景天属三种植物药不同提取部位及总黄酮抗肿瘤作用研究[J]. 中央民族大学学报(自然科学版), 2011, 20(2): 88-92. DOI: 10.3969/j.issn.1005-8036.2011.02.020.
|
[21] |
YU K, HUANG K, TANG Z Y, et al. Metabolism and antioxidation regulation of total flavanones from Sedum sarmentosum Bunge against high-fat diet-induced fatty liver disease in Nile tilapia (Oreochromis niloticus)[J]. Fish Physiology and Biochemistry, 2021, 47(4): 1149-1164. DOI: 10.1007/s10695-021-00964-3.
|
[22] |
潘金火, 潘萍. 垂盆草总黄酮中8种单体成分对肝细胞的保护作用[J]. 中国医院药学杂志, 2010, 30(19): 1621-1623.
|
[23] |
祝德秋, 刘皋林. 木樨草素的药理作用研究进展[J]. 中国药房, 2010, 21(19): 1807-1810.
|
[24] |
王亚茹, 袁满, 张丽, 等. 槲皮素抗氧化作用及相关机制研究进展[J]. 营养学报, 2022, 44(2): 204-208. DOI: 10.13325/j.cnki.acta.nutr.sin.2022.02.001.
|
[25] |
MORIKAWA T, ZHANG Y, NAKAMURA S, et al. Bioactive constituents from Chinese natural medicines. XXII. Absolute structures of new megastigmane glycosides, sedumosides E1, E2, E3, F1, F2, and G, from Sedum sarmentosum (Crassulaceae)[J]. Chemical & Pharmaceutical Bulletin, 2007, 55(3): 435-441. DOI: 10.1248/cpb.55.435.
|
[26] |
YOSHIKAWA M, MORIKAWA T, ZHANG Y, et al. Megastigmanes and their glucosides from the whole plant of Sedum sarmentosum[J]. Journal of Natural Products, 2007, 70(4): 575-583. DOI: 10.1021/np068059s.
|
[27] |
NINOMIYA K, MORIKAWA T, ZHANG Y, et al. Bioactive constituents from Chinese natural medicines. XXIII. Absolute structures of new megastigmane glycosides, sedumosides A4, A5, A6, H, and I, and hepatoprotective megastigmanes from Sedum sarmentosum[J]. Chemical & Pharmaceutical Bulletin, 2007, 55(8): 1185-1191. DOI: 10.1248/cpb.55.1185.
|
[28] |
MURAOKA O, MORIKAWA T, ZHANG Y, et al. Novel megastigmanes with lipid accumulation inhibitory and lipid metabolism-promoting activities in HepG2 cells from Sedum sarmentosum[J]. Tetrahedron, 2009, 65(21): 4142-4148. DOI: 10.1016/j.tet.2009.03.040.
|
[29] |
MA X H, YANG J, DENG S H, et al. Two new megastigmanes from Chinese traditional medicinal plant Sedum sarmentosum[J]. Natural Product Research, 2017, 31(13): 1473-1477. DOI: 10.1080/14786419.2017.1280493.
|